Selecting and Characterizing Monoclonal Antibodies for Apolipoproteins A-I and B
Author Information
Author(s): Santica Marcovina, Linda K. Curtiss, Ross Milne, John J. Albers
Primary Institution: International Federation of Clinical Chemistry (IFCC)
Hypothesis
Monoclonal antibodies can be effectively used to measure plasma levels of apolipoproteins A-I and B.
Conclusion
The study outlines important considerations for generating and selecting suitable monoclonal antibodies for measuring apolipoproteins A-I and B.
Supporting Evidence
- Monoclonal antibodies offer high specificity and can be produced in large amounts.
- Generating suitable monoclonal antibodies is difficult and time-consuming.
- Antigenic determinants can be concealed by complex interactions in native lipoproteins.
Takeaway
This study helps scientists choose the right antibodies to measure important proteins in the blood that can predict heart disease.
Methodology
The document provides recommendations for generating and selecting high-affinity monoclonal antibodies for immunoassays.
Potential Biases
Potential cross-reactivity and specificity issues with monoclonal antibodies are noted.
Limitations
The study does not provide specific data on the effectiveness of the recommended antibodies in clinical settings.
Want to read the original?
Access the complete publication on the publisher's website